List of works by Craig Gedye

A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells.

scientific article published on 29 October 2013

A new geometry for tetramanganese: fused open cubanes

ANZUP MDT Masterclass Convenor Welcome

scientific article published on 01 July 2019

ATIM-16. PHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM)

Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer

scientific article published on 23 April 2020

Canadian guideline on genetic screening for hereditary renal cell cancers

scientific article published on September 2013

Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma

scientific article published on 28 April 2016

Cancer stem cells in urologic cancers.

scientific article

Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells.

scientific article

Cell surface profiling using high-throughput flow cytometry: a platform for biomarker discovery and analysis of cellular heterogeneity

scientific article

Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal Cancer.

scientific article published on 24 February 2018

Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities.

scientific article

Current and Evolving Methods to Visualize Biological Data in Cancer Research

scientific article

Durable Response of Metastatic Squamous Cell Carcinoma of the Skin to Ipilimumab Immunotherapy.

scientific article published on 28 September 2016

ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer

scientific article published on 01 June 2008

Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine

scientific article

Enlisting the willing: A study of healthcare professional-initiated and opt-in biobanking consent reveals improvement opportunities throughout the registration process

scientific article

Escherichia coli PII protein: purification, crystallization and oligomeric structure.

scientific article published on January 1994

Forsaking cures for cancer: why are we discarding the tumour biospecimens of most patients?

scientific article published in May 2016

Human perforin mutations and susceptibility to multiple primary cancers

scientific article

Immunotherapy of advanced or metastatic melanoma.

scientific article published on December 2007

Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013

scientific article published on July 2013

Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro

scientific article published on 30 October 2015

New treatments for metastatic melanoma ⬇️

scientific article

Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus

scientific article

Optimising treatment for Australian melanoma patients can save taxpayers millions of dollars annually.

scientific article published in February 2015

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

scientific article published on 12 September 2018

Patients' experiences and preferences for opt-in models and health professional involvement in biobanking consent: A cross-sectional survey of Australian cancer outpatients.

scientific article published on 23 March 2018

Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients

scientific article published on 4 October 2016

Predicting clinical outcome through molecular profiling in stage III melanoma.

scientific article published in August 2008

Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract

scientific article published on 23 March 2019

RBTT-07. NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS

Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma.

scientific article published on 31 December 2015

Research Perspective on Utilizing and Valuing Tumor Biobanks

scientific article published on 21 December 2018

Results of a Prospective Phase 2 Pilot Trial of 177Lu–PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression

scientific article published in February 2019

Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile

scientific article

Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored ⬇️

scientific article published on 03 April 2020

Superoxide is an antagonist of antiinflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase

scientific article

Targeting the TSH receptor in thyroid cancer.

scientific article published on 28 March 2017

The Ludwig institute for cancer research Melbourne melanoma cell line panel

scientific article published on 11 April 2013

The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological Variables

scientific article published on 25 November 2019

The RANK-RANKL axis: an opportunity for drug repurposing in cancer?

scientific article published on 17 January 2019

The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis

scientific article published on 27 November 2019

The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.

scientific article

Paulina is supported by:

About Paulina

Help